EGFR and cancer: The overactivation of EGFR and downstream signaling pathways in cancer cells can be triggered by different mechanisms, such as the overproduction of ligands and EGFR proteins; deficiency of EGFR protein turnover; existence of EGFR mutations, which cause the constitutive activation of EGFR; and cross-talk with alternative cell-surface receptors [40].